Noveris Health Sciences is trading 11.76% down now at CA$0.07, continuing its decline from CA$0.09 on September 14, 2026, primarily amid broad biotech weakness and risk-off sentiment.
- No new company-specific catalyst was identified on September 15.
- The latest reported corporate update was September 9 shareholder approval of annual-meeting resolutions, including director elections.